66215-608Level 3
UPTRAVI (Selexipag)
**Product type:** Human Prescription Drug
**Active ingredient:** SELEXIPAG
**Strength:** 800 ug/1
**Dosage form:** Tablet, Coated
**Route:** Oral
**Labeler:** Actelion Pharmaceuticals US, Inc.
**Marketing category:** NDA (NDA207947)
**Pharmacologic class:** Prostacyclin Receptor Agonist [EPC], Prostacyclin Receptor Agonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/66215-608Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.